Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 18 430.0 |
96 | EP file number | EAKZ | 01 98 8712.4 |
86 | WO file number | WAKZ | PCT/EP01/12442 |
97 | EP publication number | EPN | 1332137 |
87 | WO publication number | WPN | 2002034727 |
54 | Designation/title | TI | BEHANDLUNG VON GASTROINTESTINALEN STROMATUMOREN |
51 | IPC main class | ICM (ICMV) | A61K 31/506 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01) |
22 | DE application date | DAT | Oct 26, 2001 |
96 | EP application date | EAT | Oct 26, 2001 |
86 | WO application date | WAT | Oct 26, 2001 |
43 | Date of first publication | OT | May 2, 2002 |
| Date of publication of grant | PET | Mar 29, 2006 |
71/73 | Applicant/owner | INH | Dana-Farber Cancer Institute, Inc., Boston, Mass., US; Novartis AG, 4056 Basel, CH; Oregon Health & Science University, Portland, Oreg., US; The Brigham and Women's Hospital, Inc., Boston, Mass., US |
72 | Inventor | IN | BUCHDUNGER, Elisabeth, 79395 Neuenburg, DE; CAPDEVILLE, Renaud, F-68400 Riedesheim, FR; DEMETRI Daniel, George, Brookline, MA 02445, US; DIMITRIJEVIC, Sasa, F-68170 Rixheim, FR; DRUKER J., Brian, Portland, OR 97239-1354, US; FLETCHER A., Jonathan, Brookline, MA 02446, US; JOENSUU c/oHelsinki Univ Central Hospital, Heikki, FIN-00029 Helsinki, FI; SILBERMAN Leta, Sandra, Randolph, NJ 07869, US; TUVESON, David, Berwyn, PA 19312, US; HEINRICH C., Michael, Lake Oswego, OR 97035, US |
10 | Published DE documents | DEPN | Original document:
DE000060118430T2 Searchable text:
DE000060118430T2 |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 243810 P Oct 27, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
81 | Designated WO countries | WDS | SI |
| Published EP/WO documents | EPWOPN | Original document:
EP000001332137 Searchable text:
EP000001332137 Original document:
EP000001332137B1 Searchable text:
EP000001332137B1 Original document:
WO002002034727 Searchable text:
WO002002034727 |
43 | Date of first publication | EVT | May 2, 2002 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 28, 2021 (Show all update days)(Hide all update days)- Oct 28, 2021; Jul 23, 2021; Oct 16, 2020; Oct 23, 2019; Oct 23, 2018; Oct 25, 2017; Nov 3, 2016; Nov 11, 2015; Nov 5, 2015; Oct 26, 2015; Apr 21, 2015; Nov 13, 2014; Nov 5, 2014; Mar 8, 2014; Nov 9, 2013; Nov 2, 2013; Jan 27, 2013; Nov 6, 2012; Nov 2, 2012
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 16, 2008 |
| Issue number | HN | 38 |
| Year | PJ | 2008 |
| Publication date | VT | Sep 18, 2008 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Dana-Farber Cancer Institute, Inc., Boston, Mass., US; Novartis AG, 4056 Basel, CH; Oregon Health & Science University, Portland, Oreg., US; The Brigham and Women's Hospital, Inc., Boston, Mass., US |
71/73 | Previous applicant/owner | INHF | Novartis AG, 4056 Basel, CH |